Multicenter prospective observational study of elderly functional assessment and sarcopenia assessment in patients over 75 years of age with resectable pancreatic cancer.

Multicenter prospective observational study of elderly functional assessment and sarcopenia assessment in patients over 75 years of age with resectable pancreatic cancer. - Multicenter prospective observational study of elderly functional assessment and sarcopenia assessment in patients over 75 years of age with resectable pancreatic cancer.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049084

Enrollment

Registered

2022-10-01

Start date

2022-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Clinically and radiologically consistent with resectable pancreatic cancer. 2) Patient is older than 75 years at the time of enrollment. 3) Patients have a histological diagnosis of cancer or suspected cancer, or a cytological diagnosis of class IV or V. 4) Diagnosed between December 1, 2022 and November 30, 2023. 5) No history of treatment for pancreatic cancer. 6)Able to perform elderly functional assessment and sarcopenia assessment. 7) The patient's informed consent has been obtained in writing. 8) No overlapping cancers under treatment. Translated with www.DeepL.com/Translator (free version)

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Overall survival	—

Countries

Japan

Contacts

Public ContactNobuaki Azemoto

Matsuyama Red Cross Hospital Center for Liver-Biliary-Pancreatic Diseases

azemotonobu@gmail.com089-924-1111

Outcome results